NRx Pharmaceuticals detailed plans for HOPE Therapeutics clinics launch, while Matthew Rockefeller joined the advisory board and Global Passion Project offered support.
3 reports, 2 independent
Updated Sep 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NRx Pharmaceuticals detailed plans for HOPE Therapeutics clinics launch, while Matthew Rockefeller joined the advisory board and Global Passion Project offered support.
How it developed
Newest first. Tap a step to see who reported it.- HOPE Therapeutics is closing the acquisition of Dura Medical, which operates clinics on Florida's west coast.Sub-event
NRx detailed plans for HOPE Therapeutics clinics launch; Matthew Rockefeller joined advisory board.1 source
Coverage
Newest first; wire copies grouped- TipRanksNRx Pharmaceuticals presents two keynote talks at 2025 Global Passion Project NRx Pharmaceuticals (NRXP) presented two keynote talks to a gathering of leading family offices and family members sponso
- GlobeNewswireUPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office NRx CEO presented plan
- GlobeNewswireNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital NRx CEO presented plans for HOPE Therapeutics rollout i